Osteoarthritis Clinical Trial
Official title:
Collaborative Model of Care Between Orthopaedics and Allied Healthcare Professionals Trial (CONnACT)
Verified date | October 2021 |
Source | Tan Tock Seng Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Osteoarthritis knee is the leading cause of chronic disability among older adults. Our current model of care is doctor-centric and inefficient leading to suboptimal use of allied health intervention for effective lifestyle and behaviour changes resulting in potentially, unnecessary surgery. The study is designed using an effectiveness-implementation hybrid study design utilizing a mixed methods approach. The hybrid study has dual aims. The primary aim is to evaluate the clinical effectiveness (pain, function and quality of life) of a 12-week multidisciplinary (Orthopaedics, Physiotherapy, Dietetics, Psychology) personalized, community-based program for patients with knee osteoarthritis through a randomized-controlled trial. The secondary aim is to obtain data that will inform the context for implementation and guide future wider scale application. The investigators hypothesize that this multidisciplinary program is clinically more effective in the treatment of knee osteoarthritis at 12 months compared to standard care.
Status | Active, not recruiting |
Enrollment | 114 |
Est. completion date | December 31, 2021 |
Est. primary completion date | February 1, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 45 Years to 99 Years |
Eligibility | Inclusion Criteria 1. National Institute for Health and Care Excellence (NICE) clinical criteria for knee osteoarthritis 2. Radiographic severity of knee osteoarthritis - Kellgren Lawrence Score > 1 3. Knee Injury and Osteoarthritis Outcome Score (KOOS4) = 75 4. Independent community ambulator with or without walking aid 5. Age = 45 years old 6. Conversant in English/Chinese 7. Subject will need to fulfill all the inclusion criteria for eligibility. Exclusion Criteria 1. Alternative diagnosis to knee osteoarthritis e.g. referred pain from the spine or hip 2. Secondary arthritis e.g. inflammatory, post-traumatic 3. Inability to comply with study protocol e.g. cognitive impairment 4. Previous knee arthroplasty on the symptomatic knee 5. Wheelchair bound patients 6. Any other medical condition that study team determines may interfere with study involvement |
Country | Name | City | State |
---|---|---|---|
Singapore | St Luke Eldercare (AMK) | Singapore | |
Singapore | Tan Tock Seng Hospital | Singapore |
Lead Sponsor | Collaborator |
---|---|
Tan Tock Seng Hospital | Nanyang Technological University, Singapore General Hospital, University of Southern Denmark, University of Sydney |
Singapore,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Cumulative Analgesia Consumption Score (CACS) | Objective measurement of patient's analgesics average weekly consumption based on the quantity multiplied by the category of analgesic medication according to the WHO pain relief ladder(1 point - non-opioid, 2 points - mild opioid, 3 points - strong opioid) in order to calculate a total score. | Assessed at baseline, 3 months, 6 months, 12 months | |
Other | Semi-Quantitative Food Frequency Questionnaire (FFQ) | Understand the eating habits and dietary choice over time. 64 question questionnaire looking at the frequency of food consumption in different food group on a 5 point scale ranging from less than 3 times a month to more than once a day. | Assessed at baseline, 3 months, 6 months, 12 months | |
Other | Sports Injury Rehabilitation Adherence Scale (SIRAS) | A measurement of the patient's compliance level to exercises done by the attending therapist. 3 question questionnaire with an answering scale of 1 to 5. Total score is derived from adding the 3 scores up. | Assessed after each physiotherapist session | |
Other | Global perceived effect (GPE) | Patient will be asked to rate their overall recovery on a 7-point Likert scale. 1 refers to 'Very much improved'; 7 refers to 'Very much deteriorated'. | Assessed at 3 months, 6 months, 12 months | |
Other | Patient Acceptable Symptom State (PASS) | A single-question used to assess patient's satisfaction in the treatment. Response will be either yes or no."When you think of your knee function, will you consider your current condition as satisfying? By knee function, you should take into account your activities of daily living, sport and recreational activities, your pain and other symptoms and your quality of life" | Assessed at 3 months, 6 months, 12 months | |
Other | Patient-reported Treatment failure | Patient who answers 'no' to PASS will be ask to determine if they consider the treatment to have failed. Response will be 'yes' or 'no'. "Would you consider your current state as being so unsatisfactory that you consider the treatment to have failed?" | Assessed at 3 months, 6 months, 12 months | |
Other | Costs | Cost questionnaire measuring the direct and indirect costs | Assessed at 3 months, 6 months, 12 months | |
Other | Adverse Events | Adverse events (AE) and serious adverse events (SAE) will be recorded at all follow-ups by asking the participants about potential AEs using open-probe questioning to ensure that all AEs are recorded. AEs will be categorized into index knee or other sites and will be recorded and assessed for severity independent of whether or not there is a causal relationship with study treatments. | Assessed at 3 months, 6 months,12 months | |
Other | University of California, Los Angeles(UCLA) activity score | 1 question survey to understands patient physical activity level from a scale of 1(wholly inactive) to 10(regular participation in impact sports). | Assessed at baseline, 3 months, 6 months and 12 months | |
Primary | Knee Injury and Osteoarthritis Outcomes Score (KOOS4) | Change in disease specific pain and functional outcome scores between patients undergoing the multidisciplinary community program and the current model of care will be evaluated. A composite score of the following subscales will be calculated using the averaged score - Pain, Symptoms, Activities of Daily Living and Quality of Life will be calculated. Scores between 0 and 100 represent the percentage of total possible score achieved, with zero representing extreme knee problems and 100 representing no knee problems. | Assessed at baseline, 3 months, 6 months, 12 months | |
Secondary | Knee Injury and Osteoarthritis Outcomes Score (KOOS) subscales - Pain, Symptoms, Activities of Daily Living, Sports/Recreational Activities, Quality of Life | The five patient-relevant subscales of KOOS are scored separately: KOOS Pain (9 items); KOOS Symptoms (7 items); KOOS ADL (17 items); KOOS Sport/Rec (5 items); KOOS QOL (4 items). A Likert scale is used and all items have five possible answer options scored from 0 (No Problems) to 4 (Extreme Problems) and each of the five scores is calculated as the sum of the items included. Scores are transformed to a 0-100 scale, with zero representing extreme knee problems and 100 representing no knee problems | Assessed at baseline, 3 months, 6 months, 12 months | |
Secondary | EuroQol-5 Dimensions (EQ-5D) | EuroQol-5 Dimensions (EQ-5D) which consist of 2 dimensions, the EQ-5D descriptive system and the EQ visual analogue scale (EQ VAS). The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions. This decision results in a 1-digit number that expresses the level selected for that dimension. The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state. The EQ VAS records the patient's self-rated health on a vertical visual analogue scale, where the endpoints are labelled 'The best health you can imagine' and 'The worst health you can imagine'. The VAS will be used as a quantitative measure of health outcome. | Assessed at baseline, 3 months, 6 months, 12 months | |
Secondary | Functional Assessment - 30s chair stand test | To test leg strength and endurance. Total number of repetitions completed in 30 seconds is recorded. | Assessed at baseline, 3 months, 6 months, 12 months | |
Secondary | Functional Assessment - 40m fast-paced walk test | Measure of patient's walking speed. Time taken to complete 40 meters walk will be recorded in seconds. | Assessed at baseline, 3 months, 6 months, 12 months | |
Secondary | Functional Assessment - 4 stairs climb test | To assess the strength, balance and agility through ascending and descending a set number of steps. Time to ascend and descend steps (excluding turning around time) is recorded separately in seconds. Overall time taken (including the turn around time) to ascend and descend stairs is also recorded. | Assessed at baseline, 3 months, 6 months, 12 months | |
Secondary | Functional Assessment - Timed up and go test | To assess patient's mobility and balance through the patient's ability to rise from a seated position to walk around a cone 3 meters away and return to the seated position. Time taken to perform the test in fast walking pace will be recorded in seconds. | Assessed at baseline, 3 months, 6 months, 12 months | |
Secondary | Patient Health Questionnaire 4 (PHQ-4) | Measurement for depression and anxiety rated on a 4 point Likert-type scale. 0 refers to 'Not at all'; 3 refers 'Nearly everyday'. Total score is determined by adding together the scores of each of the 4 items. Scores are rated as normal (0-2), mild (3-5), moderate (6-8), and severe (9-12).
Total score =3 for first 2 questions suggests anxiety. Total score =3 for last 2 questions suggests depression. |
Assessed at baseline, 3 months, 6 months, 12 months | |
Secondary | Patient Activation Measure (PAM) | Measures patients on a 0-100 scale and can segment patients into one of four activation levels along an empirically derived continuum. Each activation level reveals insight into an array of health-related characteristics, including attitudes, motivators, behaviors, and outcomes. | Assessed at baseline, 3 months, 6 months, 12 months | |
Secondary | Pain, Enjoyment, General Activity Scale (PEG) | Measures the pain intensity and interference level using a three-item scale. Scale of 0 to 10 is used for each item. 0 refers 'no pain'; 10 refers 'worse pain'. Add the responses to the three questions, then divide by three to get a mean score (out of 10) on overall impact of points. | Assessed at baseline, 3 months, 6 months, 12 months | |
Secondary | Body Mass Index (BMI) | Assessed if patient achieved weight loss during the study period. Weight and height of patient will be measured in m and kg respectively. Weight and height will be combined to report BMI in kg/m^2 | Assessed at baseline, 3 months, 6 months, 12 months | |
Secondary | Total Knee Replacement | Indicates if the patient undergoes a total knee replacement at any time during the study period. | Assessed at 3 months, 6 months, 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04657926 -
A Trial of APPA in the Treatment of Knee Osteoarthritis
|
Phase 2 | |
Completed |
NCT02536833 -
A Study Evaluating the Safety, Tolerability, and Efficacy of SM04690 Injected in the Target Knee Joint of Moderately to Severely Symptomatic Osteoarthritis Subjects
|
Phase 2 | |
Completed |
NCT03014037 -
Comparing Mesenchymal Stem Cell Counts in Unilateral vs. Bilateral Posterior Superior Iliac Spine Bone Marrow Aspiration
|
N/A | |
Recruiting |
NCT05937542 -
A Qualitative Investigation of CLEAT Participants
|
||
Completed |
NCT03644615 -
A Mindfulness Program (MBSR) in the Management of Symptomatic Hip and Knee Osteoarthritis
|
N/A | |
Recruiting |
NCT06061367 -
Muscles Strength and Gait Parameteres After TKA
|
||
Withdrawn |
NCT04976972 -
A Comparison of Patients Receiving a Total Knee Replacement With Robotic Assistance or With Conventional Instrumentation
|
N/A | |
Completed |
NCT05496205 -
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT03850665 -
Comparison of Functional Outcome in Patients After Hip Arthroplasty Depending on Surgical Approach
|
N/A | |
Completed |
NCT02826902 -
Effect of Anesthesia on Quality of Recovery in Patients Undergoing Correctional Tibial Osteotomy - A Randomized Controlled Trial
|
N/A | |
Completed |
NCT04402502 -
Dynamic 4DCT to Examine Wrist Carpal Mechanics
|
N/A | |
Completed |
NCT02923700 -
Leukocyte-rich PRP vs Leukocyte-poor PRP for the Treatment of Knee Cartilage Degeneration: a Randomized Controlled Trial
|
Phase 4 | |
Completed |
NCT04564053 -
Study of Safety, Tolerability and Pharmacokinetics of LNA043 in Japanese Osteoarthritis Participants
|
Phase 1 | |
Completed |
NCT05070871 -
A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women
|
N/A | |
Not yet recruiting |
NCT05036174 -
Diphenhydramine Ointment for Knee Osteoarthritis
|
N/A | |
Recruiting |
NCT02912429 -
Onlay vs. Inlay Patellofemoral Arthroplasty
|
N/A | |
Recruiting |
NCT02666443 -
Low Dose Dexamethasone in Supraclavicular Blocks
|
N/A | |
Active, not recruiting |
NCT02723929 -
Effects of tDCS and tUS on Pain Perception in OA of the Knee
|
||
Withdrawn |
NCT02921594 -
Kinematic Comparison of Vanguard XP and Vanguard CR Total Knee Arthroplasties
|
N/A | |
Terminated |
NCT02820766 -
Journey II BCS CMS Total Knee System Compared to Other PS Total Knee Systems in PT Setting
|
N/A |